ironstocklab

Bachrodt Amy

SVP, Finance · 25 insider transactions on file

All transactions

DateTickerCompanyTypeSharesPriceValueFiling
2026-04-01MAZEMaze Therapeutics, Inc.Sale2,200$29.32$64,509.94filing
2026-04-01MAZEMaze Therapeutics, Inc.Option exercise2,500$10.42$26,050.00filing
2026-04-01MAZEMaze Therapeutics, Inc.Sale300$30.34$9,101.01filing
2026-03-02MAZEMaze Therapeutics, Inc.Sale3,700$45.47$168,236.78filing
2026-03-02MAZEMaze Therapeutics, Inc.Sale1,300$44.44$57,773.82filing
2026-03-02MAZEMaze Therapeutics, Inc.Option exercise5,000$10.42$52,100.00filing
2026-02-02MAZEMaze Therapeutics, Inc.Sale4,064$46.03$187,067.95filing
2026-02-02MAZEMaze Therapeutics, Inc.Option exercise4,844$10.42$50,474.48filing
2026-02-02MAZEMaze Therapeutics, Inc.Sale736$46.63$34,321.37filing
2026-02-02MAZEMaze Therapeutics, Inc.Sale200$44.15$8,830.00filing
2026-02-02MAZEMaze Therapeutics, Inc.Option exercise156$10.42$1,625.52filing
2026-01-22MAZEMaze Therapeutics, Inc.Sale5,000$45.52$227,612.00filing
2026-01-22MAZEMaze Therapeutics, Inc.Option exercise2,503$10.42$26,081.26filing
2026-01-22MAZEMaze Therapeutics, Inc.Option exercise2,497$10.42$26,018.74filing
2026-01-02MAZEMaze Therapeutics, Inc.Sale2,595$39.57$102,681.30filing
2026-01-02MAZEMaze Therapeutics, Inc.Sale2,405$38.70$93,072.30filing
2026-01-02MAZEMaze Therapeutics, Inc.Option exercise4,796$10.42$49,974.32filing
2026-01-02MAZEMaze Therapeutics, Inc.Option exercise204$10.42$2,125.68filing
2025-12-30MAZEMaze Therapeutics, Inc.Sale5,000$40.08$200,407.00filing
2025-12-30MAZEMaze Therapeutics, Inc.Option exercise2,605$10.42$27,144.10filing
2025-12-30MAZEMaze Therapeutics, Inc.Option exercise2,395$10.42$24,955.90filing
2025-12-29MAZEMaze Therapeutics, Inc.Sale9,400$40.54$381,071.30filing
2025-12-29MAZEMaze Therapeutics, Inc.Option exercise9,876$10.42$102,907.92filing
2025-12-29MAZEMaze Therapeutics, Inc.Sale600$41.16$24,694.98filing
2025-12-29MAZEMaze Therapeutics, Inc.Option exercise124$10.42$1,292.08filing

Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.